Compare · MNTX vs TMO
MNTX vs TMO
Side-by-side comparison of Manitex International Inc. (MNTX) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- MNTX operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $232.26B, about 1676.3x MNTX ($138.6M).
- TMO has hit the wire 10 times in the past 4 weeks while MNTX has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 2 for MNTX).
- Company
- Manitex International Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $138.6M
- $232.26B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 10
- Recent ratings
- 2
- 25
Manitex International Inc.
Manitex International, Inc. provides engineered lifting solutions in the United States, Italy, Canada, France, Chile, and internationally. It designs, manufactures, and distributes products that are used in various industries. The company also offers boom trucks, truck cranes, and sign cranes products primarily for use in industrial projects, energy exploration, and infrastructure development comprising roads, bridges, and commercial construction. In addition, it manufactures and sells rough terrain cranes and material handling products for construction, municipality, and railroad industries; truck mounted hydraulic knuckle boom cranes; and shipping articulated cranes. The company provides its products under the Manitex, PM, MAC, PM-Tadano, Oil & Steel, Badger, and Valla brands. It also sells its products through dealers and rental distribution channel. The company was formerly known as Veri-Tek International, Corp. and changed its name to Manitex International, Inc. in May 2008. Manitex International, Inc. was founded in 1993 and is headquartered in Bridgeview, Illinois.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MNTX
- SEC Form 15-12G filed by Manitex International Inc.
- SEC Form EFFECT filed by Manitex International Inc.
- BGL Announces Manitex International Completes the Closing of its Acquisition by Tadano Ltd.
- Director Tober Stephen returned 127,005 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Knox Frederick B returned 90,517 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Clark Ronald Michael returned 107,517 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Financial Officer Doolan Joseph covered exercise/tax liability with 3,461 shares, was granted 50,000 shares and returned 140,397 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Executive Chairman Langevin David J covered exercise/tax liability with 5,395 shares and returned 975,190 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Executive Officer Coffey Michael returned 1,044,500 shares to the company and was granted 400,000 shares, closing all direct ownership in the company (SEC Form 4)
- Amendment: SEC Form SC 13E3/A filed by Manitex International Inc.
Latest TMO
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 31 shares, decreasing direct ownership by 0.53% to 5,830 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 20,000 shares at a strike of $309.63 and sold $12,561,823 worth of shares (20,000 units at $628.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $7,014,093 worth of shares (11,440 units at $613.12) and exercised 11,440 shares at a strike of $418.32, decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Executive Vice President Shafer Michael D exercised 25,500 shares at a strike of $370.58 and sold $15,300,000 worth of shares (25,500 units at $600.00) as part of a pre-agreed trading plan (SEC Form 4)
- Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
- VP & Chief Accounting Officer Holmes Joseph R. exercised 420 shares at a strike of $309.63 and sold $245,620 worth of shares (420 units at $584.81) (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $2,862,002 worth of shares (4,883 units at $586.12) as part of a pre-agreed trading plan (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. exercised 5,850 shares at a strike of $309.63 and sold $3,393,000 worth of shares (5,850 units at $580.00), decreasing direct ownership by 0.00% to 14,784 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,616,967 worth of shares (15,000 units at $574.46) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)
- Chairman & CEO Casper Marc N exercised 10,000 shares at a strike of $309.63 and sold $8,628,434 worth of shares (15,000 units at $575.23) as part of a pre-agreed trading plan, decreasing direct ownership by 0.00% to 123,925 units (SEC Form 4)